KaloBios Sacks CEO Shkreli
This article was originally published in Scrip
Executive Summary
KaloBios Pharmaceuticals Inc. has fired CEO Martin Shkreli following his arrest for securities fraud on Dec. 17, 2015. Shkreli has also resigned from the company's board of directors and stepped down as CEO of Turing Pharmaceuticals, Inc. KaloBios has not yet named an interim or replacement CEO.